Dow Down 1.21% Nasdaq Down 1.32%

Novavax, Inc. (NVAX)

-NasdaqGS
4.09 Down 0.09(2.04%) 12:57PM EDT - Nasdaq Real Time Price
Prev Close:4.17
Open:4.17
Bid:4.07 x 13100
Ask:4.08 x 3300
1y Target Est:10.58
Beta:1.04
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.02 - 4.18
52wk Range:2.68 - 6.95
Volume:2,004,791
Avg Vol (3m):2,963,140
Market Cap:972.65M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 2.04%972.65M
MRKDown 0.85%169.54B
NVSDown 0.82%226.51B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):33.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback